U.S. Sen. Tammy Baldwin
Press Release

Baldwin Applauds First 10 Drugs Announced for Medicare Price Negotiation Under Inflation Reduction Act

9 Million Americans spent more than $3.4 billion on these 10 drugs to treat life-threatening conditions like diabetes, heart disease and cancer

By - Aug 29th, 2023 11:48 am

WASHINGTON, D.C. – Today, Senator Tammy Baldwin (D-WI) is applauding the first 10 drugs selected for Medicare price negotiation under the Baldwin-backed Inflation Reduction Act. The law, which allows Medicare to negotiate the price of dozens of drugs with manufacturers for the first time ever, will cut out-of-pocket costs for seniors, save American taxpayers billions of dollars, and reduce the deficit. In 2022 alone, approximately 9 million seniors and other Medicare beneficiaries spent over $3.4 billion out-of-pocket on the 10 drugs selected for negotiation. Millions of Part D enrollees depend on these vital drugs to treat life-threatening conditions including diabetes, heart failure, and cancer, but many struggle to access their medications because of prohibitive costs.

Earlier this week, Senator Baldwin sent a letter calling on the Biden administration to include several of these same high-priced and widely used drugs that will have the greatest impact for Wisconsinites.

“No Wisconsinite should go broke just to afford the medications they need to stay healthy. Our Inflation Reduction Act finally took on big drug companies and is lowering drug prices, reducing out-of-pocket costs for families and saving taxpayers billions of dollars,” said Senator Baldwin. “I am so proud that our work is lowering drug prices and providing support for tens of thousands of Wisconsinites who rely on these drugs to treat heart disease, diabetes and cancer.”

Negotiations for the first group of selected drugs will begin in 2023, with negotiated prices going into effect in 2026. The number of drugs subject to price negotiation will increase over time. According to the Congressional Budget Office, this provision from the Inflation Reduction Act is estimated to lower average drug prices in Medicare and will reduce the budget deficit by $25 billion in 2031.

This historic provision in the Inflation Reduction Act is just one way the legislation is lowering health care costs for Wisconsinites. The Baldwin-backed law is also capping the cost of insulin for seniors at $35 per month, making no-cost vaccines available to Wisconsinites on Medicare, and penalizing drug companies that raise prices faster than inflation.

An online version of this release is available here.

NOTE: This press release was submitted to Urban Milwaukee and was not written by an Urban Milwaukee writer. While it is believed to be reliable, Urban Milwaukee does not guarantee its accuracy or completeness.

Mentioned in This Press Release

Recent Press Releases by U.S. Sen. Tammy Baldwin

Baldwin Secures $13.4 Million for New Business Accelerator to Support Great Lakes Economy and Resiliency

Announcement comes after Baldwin called on NOAA to invest in the Great Lakes

Baldwin, Vance Bipartisan Bill to Ensure Taxpayer-Funded Inventions Are Made in America Passes Senate

Invent Here, Make Here Act expands Baldwin-championed requirements to manufacture cutting-edge technologies in the U.S.

Leave a Reply

You must be an Urban Milwaukee member to leave a comment. Membership, which includes a host of perks, including an ad-free website, tickets to marquee events like Summerfest, the Wisconsin State Fair and the Florentine Opera, a better photo browser and access to members-only, behind-the-scenes tours, starts at $9/month. Learn more.

Join now and cancel anytime.

If you are an existing member, sign-in to leave a comment.

Have questions? Need to report an error? Contact Us